Successful treatment of C1q nephropathy with CD19 targeted Rituximab therapy

Nephrology (Carlton). 2017 Mar;22(3):265. doi: 10.1111/nep.12757.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Female
  • Glomerulonephritis / drug therapy*
  • Humans
  • Immunologic Factors / therapeutic use*
  • Rituximab / therapeutic use*

Substances

  • Immunologic Factors
  • Rituximab